Most of the "GMP consultants" a supplement brand finds in a Google search are quality generalists who added dietary supplements to a service list somewhere between food safety and cosmetics. That's not a knock on generalist quality consulting — it's a real discipline. But 21 CFR Part 111 is not ISO 9001 with a different cover page, and a consultant who hasn't lived inside it will miss the things that actually get supplement facilities cited.
I've built this piece as a straight answer to the question I get most from dietary supplement manufacturers: what should I actually be looking for, and what does a consultant who knows this regulation cold do differently from one who's guessing?
What "GMP Consultant for Dietary Supplements" Actually Means
Dietary supplements sit in their own regulatory lane. They're not drugs, so 21 CFR Parts 210 and 211 don't apply. They're not conventional food in the FSMA sense, so 21 CFR Part 117 doesn't apply either. Congress created a separate category for them in the Dietary Supplement Health and Education Act of 1994 (DSHEA). FDA finalized the manufacturing rule for that category as 21 CFR Part 111 — "Current Good Manufacturing Practice in Manufacturing, Packaging, Labeling, or Holding Operations for Dietary Supplements" — published June 25, 2007 (72 FR 34751). The compliance schedule was phased, running through June 2010 for small businesses.
That distinction matters because a consultant whose background is drug GMP or food safety will instinctively reach for the wrong framework. Part 111 has its own definitions, its own specification and testing scheme, and its own recordkeeping architecture. A "GMP consultant for dietary supplements" is someone whose day-to-day expertise is built around this specific part of the code, not someone applying a drug or food playbook and hoping it transfers.
Why 21 CFR Part 111 Is Its Own Animal
Three provisions inside Part 111 trip up more facilities than anything else I see, and they're worth naming specifically because they're the clearest test of whether a consultant actually knows this regulation.
Component identity testing. 21 CFR 111.75(a)(1) requires that you conduct at least one appropriate test or examination to verify the identity of every component that is a dietary ingredient — there is no supplier-CoA exemption from this. The only way around 100% identity testing is petitioning FDA for an alternative under 111.75(a)(1)(ii). Where a qualified supplier CoA does carry weight is on the other specs — purity, strength, and composition — under 111.75(a)(2). A lot of facilities blur that line and treat a qualified CoA as covering identity too. It doesn't, and doing so is one of the most commonly cited Part 111 violations there is.
Specifications, not just SOPs. 111.70 requires you to establish specifications for the identity, purity, strength, and composition of components, and for the identity, purity, strength, composition, and limits on contaminants of the finished batch. Having procedures without documented specifications tied to test methods is a common gap — one that's easy to miss if you're auditing against a general quality management system checklist instead of Part 111 itself.
Master manufacturing records. 111.210 requires a master manufacturing record for every batch size and formulation you produce, and 111.260 requires a batch record that follows it exactly. Facilities that scaled up fast, especially contract manufacturers running many SKUs, often have MMRs that drifted out of sync with what's actually happening on the line. That's a specific, checkable gap, and it's the kind of thing a supplement-specific gap assessment finds in the first pass.
I mention these three because they're not obscure. They're the load-bearing clauses of Part 111, and a consultant who can't speak fluently to all three probably hasn't spent real time inside this regulation.
The Gaps I See Most Often in Supplement Facilities
Beyond the three provisions above, the pattern I run into most is qualification: 111.12 requires that personnel performing quality control operations have the education, training, or experience to do so, and that this qualification be documented. It's not enough to have a competent QC team — the file has to show why they're qualified for the specific role they hold. Facilities that grew organically, promoting production staff into quality roles as headcount increased, frequently have the competence but not the paper trail.
Supplier qualification is the second recurring gap. 111.75(a)(2) lets you reduce component testing for purity, strength, and composition by relying on a supplier's certificate of analysis — but only once you've determined that CoA is reliable, and that determination has to be based on more than the fact that a CoA exists. I've written more detail on how that qualification process should actually run in the GMP supplier and vendor qualification guide.
Contamination control rounds out the list. Salmonella and other pathogen risks in supplement manufacturing get less regulatory attention than they do in food, but Part 111's environmental monitoring and hygiene provisions (Subpart B and Subpart D) apply just as much to a powder-blending operation as they do to a food plant, and the consequences of missing them are the same kind of recall.
What a Supplement-Focused GMP Consultant Should Actually Do
A real engagement has a shape, and it's not "come in and write some SOPs." It starts with a gap assessment against Part 111 specifically, clause by clause, not against a generic quality checklist. It produces a written list of findings tied to the actual regulatory citation, not vague language like "improve documentation practices." It includes a mock FDA inspection, because the first time your team should have to explain a deviation to an investigator should not be during a real inspection. And it ends with a corrective action plan with real owners and real dates, not a binder that sits on a shelf.
If a consultant's proposal doesn't mention Part 111 by number, or talks about "GMP" in the abstract without distinguishing drug GMP from supplement GMP, that's worth asking about directly before you sign anything.
Generalist Quality Consultant vs. Dietary-Supplement-Specific GMP Consultant
| Criteria | Generalist Quality Consultant | Dietary-Supplement-Specific GMP Consultant |
|---|---|---|
| Regulatory framework applied | Often ISO 9001 or a blended "GMP" template | 21 CFR Part 111, clause by clause |
| Identity testing guidance | May accept a qualified supplier CoA in place of identity testing | Knows 111.75(a)(1) identity testing has no CoA-based exemption absent an FDA-approved petition under 111.75(a)(1)(ii) |
| Specification review | Focused on procedures existing | Verifies specifications under 111.70 tie to actual test methods |
| Batch record review | General document control lens | Checks MMR-to-batch-record fidelity under 111.210/111.260 |
| Mock inspection format | Generic audit walkthrough | Modeled on how FDA investigators actually work a Part 111 inspection |
| Personnel qualification | Assumes training records suffice | Verifies documented basis for QC role qualification under 111.12 |
How to Vet a Dietary Supplement GMP Consultant
Bring this into the vendor call. The answers should be immediate and specific, not general.
- Identity testing. Ask the consultant to walk you through the 111.75 identity-testing requirement without looking it up — what it requires, and the one narrow exemption path.
- Specifications vs. in-process controls. Ask what the difference is between a specification under 111.70 and an in-process control.
- Supplier CoA reliability. Ask how they'd handle a facility that's been accepting supplier CoAs without a documented reliability determination on file.
- Credentials. Ask what credentials back their regulatory judgment. (My own background combines a JD, an MBA, and certifications across quality and regulatory affairs — PMP, CMQ-OE, CQA, CPGP, and RAC — because this work sits at the intersection of regulatory interpretation, quality systems, and legal exposure.)
- First 90 days. Ask what they'd actually deliver in the first 90 days. If the answer is vague, that's the tell — it should read as a sequence of concrete milestones, not a retainer with no defined endpoint. I've laid out what that looks like in the GMP first 90 days guide.
Why Certify Consulting's Approach Fits This Niche
Certify Consulting's approach to dietary supplement engagements starts from the regulation, not from a generic quality template. That means the gap assessment is built around Part 111's actual subparts — personnel, physical plant, equipment, production and process controls, quality control, and returned product handling — and the findings are written so a plant manager can act on them without a translator.
It also means the scope matches the subparts that actually apply. A small or mid-sized supplement manufacturer doesn't need drug-GMP-scale environmental controls or a sterile-manufacturing quality system bolted onto a powder-blending line that's never handled sterile product — it needs a system that satisfies Part 111's actual subparts and holds up against what an FDA investigator checks, not a template built for a different regulation. That's the distinction between a consultant applying a framework they know well and one applying the specific framework the FDA will actually inspect against. You can see the broader case for what separates a strong GMP consultant from the field in the best GMP consultant guide, and the dietary supplements service page lays out how that translates into an actual engagement scope.
Frequently Asked Questions
What regulation governs dietary supplement manufacturing?
21 CFR Part 111, finalized June 25, 2007 (72 FR 34751) under authority granted by the Dietary Supplement Health and Education Act of 1994. It covers manufacturing, packaging, labeling, and holding operations and is distinct from drug GMP (21 CFR Parts 210/211) and food safety rules (21 CFR Part 117).
How is dietary supplement GMP different from drug GMP?
Part 111 has its own component identity testing requirement (111.75), its own specification scheme (111.70), and its own master manufacturing record structure (111.210/111.260). Drug GMP under Parts 210/211 has parallel concepts but different thresholds and different documentation expectations. A consultant fluent in one is not automatically fluent in the other.
Do I need to test every raw material for identity?
Yes. 21 CFR 111.75(a)(1) requires at least one appropriate identity test on every dietary-ingredient component, and a supplier's certificate of analysis — however well qualified — does not substitute for it. The only exemption path is an FDA-approved alternative under 111.75(a)(1)(ii). Relying on a qualified CoA in place of identity testing is one of the most commonly cited Part 111 violations there is.
How long does a dietary supplement GMP gap assessment take?
It depends on facility size and product complexity, but a proper assessment walks every subpart of Part 111 against your actual operation, not a generic checklist, and produces findings tied to specific clause numbers so your team knows exactly what to fix and why.
What should the first deliverable from a GMP consultant look like?
A written gap assessment citing specific Part 111 clauses, not general observations. If the first document you receive doesn't reference the regulation by number, ask why.
Last updated: 2026-08-28
Jared Clark
GMP Compliance Consultant, Certify Consulting
Jared Clark is a GMP compliance consultant and founder of Certify Consulting, specializing in FDA GMP requirements for pharmaceuticals, dietary supplements, cosmetics, and food manufacturing.